BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 32679278)

  • 21. Irradiated Skeletal Muscle Cells Mimicking Those of Atypical Fibroxanthoma on Mohs Frozen Sections.
    Xiong MY; Kolker S; Bennett RG
    Am J Dermatopathol; 2021 May; 43(5):362-364. PubMed ID: 32956095
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Atypical fibroxanthoma-a diagnosis of exclusion!
    Tchernev G; Tronnier M; Ananiev J; Taneva T; Patterson JW; Gulubova M; Trafeli JP; Gegova A; Harrell M; Guarneri C; Wollina U; Cardoso JC; Kanazawa N; Zisova L; Forsea AM; Zouboulis CC
    Wien Med Wochenschr; 2013 Aug; 163(15-16):380-6. PubMed ID: 23319144
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Localized cutaneous metastases from an atypical fibroxanthoma.
    Giuffrida TJ; Kligora CJ; Goldstein GD
    Dermatol Surg; 2004 Dec; 30(12 Pt 2):1561-4. PubMed ID: 15606841
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A case of cutaneous malignant fibrous histiocytoma with multiple organ metastases.
    Suzuki S; Watanabe S; Kato H; Inagaki H; Hattori H; Morita A
    Kaohsiung J Med Sci; 2013 Feb; 29(2):111-5. PubMed ID: 23347814
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Review: Dermatofibrosarcoma protuberans: histologic approach and updated treatment recommendations.
    Sundram UN
    Clin Adv Hematol Oncol; 2009 Jun; 7(6):406-8. PubMed ID: 19606077
    [No Abstract]   [Full Text] [Related]  

  • 26. Plexiform fibrohistiocytic tumor.
    Thirumala S; Rhyne CD; Bodhireddy S
    Indian J Pathol Microbiol; 2008; 51(2):245-6. PubMed ID: 18603695
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LN2, CD10, and Ezrin Do Not Distinguish Between Atypical Fibroxanthoma and Undifferentiated Pleomorphic Sarcoma or Predict Clinical Outcome.
    Hanlon A; Stasko T; Christiansen D; Cyrus N; Galan A
    Dermatol Surg; 2017 Mar; 43(3):431-436. PubMed ID: 28079637
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 3D-Histological evaluation of surgery in dermatofibrosarcoma protuberans and malignant fibrous histiocytoma: differences in growth patterns and outcome.
    Häfner HM; Moehrle M; Eder S; Trilling B; Röcken M; Breuninger H
    Eur J Surg Oncol; 2008 Jun; 34(6):680-6. PubMed ID: 17716851
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Malignant fibrous histiocytoma in a scar from excision of a melanocytic nevus].
    Conejero R; Rivera I; Ara M; Carapeto FJ
    Actas Dermosifiliogr; 2011 Oct; 102(8):642-4. PubMed ID: 21571244
    [No Abstract]   [Full Text] [Related]  

  • 30. Atypical fibroxanthoma: a series of 56 tumors and an unexplained uneven distribution of cases in southeast Germany.
    Wollina U; Schönlebe J; Ziemer M; Friedling F; Koch A; Haroske G; Kaatz M; Simon JC
    Head Neck; 2015 Jun; 37(6):829-34. PubMed ID: 24946737
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Malignant fibrous histiocytoma].
    Sertznig P; Megahed M
    Hautarzt; 2011 May; 62(5):327-9. PubMed ID: 21431446
    [TBL] [Abstract][Full Text] [Related]  

  • 32. AFX: what we now know.
    McCalmont TH
    J Cutan Pathol; 2011 Nov; 38(11):853-6. PubMed ID: 21955311
    [No Abstract]   [Full Text] [Related]  

  • 33. Atypical Fibroxanthoma.
    Chapman LW; Yu SS; Arron ST
    Semin Cutan Med Surg; 2019 Mar; 38(1):E65-E66. PubMed ID: 31051027
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Superficial malignant fibrous histiocytoma presenting as recurrent atypical fibroxanthoma.
    Ly H; Selva D; James CL; Huilgol SC
    Australas J Dermatol; 2004 May; 45(2):106-9. PubMed ID: 15068457
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk factors for local atypical fibroxanthoma recurrence and progression to pleomorphic dermal sarcoma: A meta-analysis of individualized participant data.
    Ørholt M; Aaberg FL; Abebe K; Walsh S; Roenigk RK; Venzo A; Schmidt G; Klyver H; Jensen DH; Herly M; Vester-Glowinski PV
    J Surg Oncol; 2022 Sep; 126(3):555-562. PubMed ID: 35441377
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Atypical fibroxanthoma and pleomorphic dermal sarcoma].
    Ziemer M; Jäger IM; Dippel E
    Hautarzt; 2019 Sep; 70(9):661-669. PubMed ID: 31468069
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recurrent cutaneous malignant fibrous histiocytoma.
    Shi WM; Liao WQ; Wu ZW; Pandey P; Mei XY; Qin HH; Xu JH; Shen L
    Eur J Dermatol; 2009; 19(2):187-8. PubMed ID: 19264583
    [No Abstract]   [Full Text] [Related]  

  • 38. Case for diagnosis. Atypical fibroxanthoma.
    Hammerschmidt M; Azevedo LM; Ruaro A; Werner B; Nascimento Ad; Amaral Filho EA
    An Bras Dermatol; 2012; 87(4):647-8. PubMed ID: 22892788
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Atypical fibroxanthoma developing on a pacemaker pocket mimicking a pyogenic granuloma.
    González-Vela MC; Salcedo W; Neira C; González-López MA; Ayala H; Val-Bernal JF
    Cardiovasc Pathol; 2013; 22(1):102-4. PubMed ID: 22502867
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Delayed removal of 3M vein coupler does not disturb the anastomosis.
    Hilliard S; Pommier R; Solomon JS
    Microsurgery; 2009; 29(6):502-3. PubMed ID: 19530088
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.